NCT00329589View on ClinicalTrials.gov

A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Brain CancerHead and Neck CancerCervix CancerCentral Nervous System Neoplasms
Interventions
DRUG

Velcade (bortezomib)

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER